209 related articles for article (PubMed ID: 21772333)
21. Targeting beta-catenin signaling to induce apoptosis in human breast cancer cells by z-guggulsterone and Gugulipid extract of Ayurvedic medicine plant Commiphora mukul.
Jiang G; Xiao X; Zeng Y; Nagabhushanam K; Majeed M; Xiao D
BMC Complement Altern Med; 2013 Aug; 13():203. PubMed ID: 23914993
[TBL] [Abstract][Full Text] [Related]
22. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
[TBL] [Abstract][Full Text] [Related]
24. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
[TBL] [Abstract][Full Text] [Related]
25. HS3ST2 modulates breast cancer cell invasiveness via MAP kinase- and Tcf4 (Tcf7l2)-dependent regulation of protease and cadherin expression.
Vijaya Kumar A; Salem Gassar E; Spillmann D; Stock C; Sen YP; Zhang T; Van Kuppevelt TH; Hülsewig C; Koszlowski EO; Pavao MS; Ibrahim SA; Poeter M; Rescher U; Kiesel L; Koduru S; Yip GW; Götte M
Int J Cancer; 2014 Dec; 135(11):2579-92. PubMed ID: 24752740
[TBL] [Abstract][Full Text] [Related]
26. The SxxSS motif of T-cell factor-4 isoforms modulates Wnt/β-catenin signal activation in hepatocellular carcinoma cells.
Tomimaru Y; Koga H; Shin TH; Xu CQ; Wands JR; Kim M
Cancer Lett; 2013 Aug; 336(2):359-69. PubMed ID: 23562475
[TBL] [Abstract][Full Text] [Related]
27. MENA is a transcriptional target of the Wnt/beta-catenin pathway.
Najafov A; Seker T; Even I; Hoxhaj G; Selvi O; Ozel DE; Koman A; Birgül-İyison N
PLoS One; 2012; 7(5):e37013. PubMed ID: 22615875
[TBL] [Abstract][Full Text] [Related]
28. Control of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines.
Beildeck ME; Islam M; Shah S; Welsh J; Byers SW
PLoS One; 2009 Nov; 4(11):e7872. PubMed ID: 19924301
[TBL] [Abstract][Full Text] [Related]
29. HMGA1 interacts with β-catenin to positively regulate Wnt/β-catenin signaling in colorectal cancer cells.
Xing J; Cao G; Fu C
Pathol Oncol Res; 2014 Oct; 20(4):847-51. PubMed ID: 24696416
[TBL] [Abstract][Full Text] [Related]
30. Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2.
Hikasa H; Sokol SY
J Biol Chem; 2011 Apr; 286(14):12093-100. PubMed ID: 21285352
[TBL] [Abstract][Full Text] [Related]
31. Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.
Kang DW; Min do S
PLoS One; 2010 Aug; 5(8):e12109. PubMed ID: 20711340
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the Wnt/B-catenin/TCF4 pathway using SAGE, genome-wide microarray and promoter analysis: Identification of BRI3 and HSF2 as novel targets.
Kavak E; Najafov A; Ozturk N; Seker T; Cavusoglu K; Aslan T; Duru AD; Saygili T; Hoxhaj G; Hiz MC; Unal DO; Birgül-Iyison N; Ozturk M; Koman A
Cell Signal; 2010 Oct; 22(10):1523-35. PubMed ID: 20538055
[TBL] [Abstract][Full Text] [Related]
33. A Wnt kinase network alters nuclear localization of TCF-1 in colon cancer.
Najdi R; Syed A; Arce L; Theisen H; Ting JH; Atcha F; Nguyen AV; Martinez M; Holcombe RF; Edwards RA; Marsh JL; Waterman ML
Oncogene; 2009 Nov; 28(47):4133-46. PubMed ID: 19749792
[TBL] [Abstract][Full Text] [Related]
34. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer.
Mostovich LA; Prudnikova TY; Kondratov AG; Gubanova NV; Kharchenko OA; Kutsenko OS; Vavilov PV; Haraldson K; Kashuba VI; Ernberg I; Zabarovsky ER; Grigorieva EV
Epigenetics; 2012 Aug; 7(8):930-9. PubMed ID: 22805760
[TBL] [Abstract][Full Text] [Related]
35. A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells.
Yook JI; Li XY; Ota I; Hu C; Kim HS; Kim NH; Cha SY; Ryu JK; Choi YJ; Kim J; Fearon ER; Weiss SJ
Nat Cell Biol; 2006 Dec; 8(12):1398-406. PubMed ID: 17072303
[TBL] [Abstract][Full Text] [Related]
36. ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer.
Appaiah H; Bhat-Nakshatri P; Mehta R; Thorat M; Badve S; Nakshatri H
Cancer Biol Ther; 2010 Sep; 10(6):600-14. PubMed ID: 20603605
[TBL] [Abstract][Full Text] [Related]
37. Zipper-interacting protein kinase (ZIPK) modulates canonical Wnt/beta-catenin signaling through interaction with Nemo-like kinase and T-cell factor 4 (NLK/TCF4).
Togi S; Ikeda O; Kamitani S; Nakasuji M; Sekine Y; Muromoto R; Nanbo A; Oritani K; Kawai T; Akira S; Matsuda T
J Biol Chem; 2011 May; 286(21):19170-7. PubMed ID: 21454679
[TBL] [Abstract][Full Text] [Related]
38. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
[TBL] [Abstract][Full Text] [Related]
39. The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.
Bush BM; Brock AT; Deng JA; Nelson RA; Sumter TF
Cell Biochem Funct; 2013 Apr; 31(3):228-36. PubMed ID: 22961697
[TBL] [Abstract][Full Text] [Related]
40. NGX6 inhibits cell invasion and adhesion through suppression of Wnt/beta-catenin signal pathway in colon cancer.
Guo Q; Shen S; Liao M; Lian P; Wang X
Acta Biochim Biophys Sin (Shanghai); 2010 Jul; 42(7):450-6. PubMed ID: 20705583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
